Remove Manufacturing Remove Networking Remove Pharma Remove Specialization
article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself. “For Developing best-in-class speciality enzymes.

article thumbnail

The Role of Blockchain Technology in Pharma Supply Chain Transparency

Pharma Marketing Network

In this article, we will discuss the role of blockchain technology in pharma supply chain transparency, as well as the potential benefits and challenges of implementing blockchain technology. It is based on a decentralized peer-to-peer network and is powered by cryptography. What is Blockchain Technology?

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

AI in pharma R&D is one of the latest innovations helping teams apply existing knowledge to new problems. Artificial intelligence (AI) has many implications for pharmaceutical companies, including on research, drug discovery and development, manufacturing and trials. Here are a few ways AI is used in pharma today.

Pharma 52
article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Big pharma has compelling reasons to change the way business gets done. With more than 75,000 companies in the EcoVadis network, the scorecard serves as a measurement with detailed insight into environmental, social, and ethical risks across 200 purchasing categories and 160 countries. What is Big Pharma doing to tackle climate change?

Pharma 103
article thumbnail

What Does the Metaverse Mean to Pharma?

PM360

Is the metaverse a worthwhile investment for pharma? So, should pharma be preparing for a future where this is the case? For Specialized Care: We’ve heard heroic stories of patients living in “Health Deserts” driving almost a whole day to receive specialized oncology care because they had no options in their local communities.

Pharma 97
article thumbnail

Collaboration & Agility – Core Themes & Lessons from Reuters Pharma USA 2021

Pharma Marketing Network

At this year’s Pharma USA conference, C ollaboration was the theme of the opening keynote session and a common thread woven throughout the event as industry leaders gathered to discuss how to move “Beyond Normal” to shape the future of health. At the end of the day, we are a manufacturer of medicines. Build & Scale.

Pharma 59
article thumbnail

Bob Harrell

Pharma Marketing Network

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.